A

Amerisourcebergen Corp
LSE:0HF3

Watchlist Manager
Amerisourcebergen Corp
LSE:0HF3
Watchlist
Price: 323.26 USD 1.82%
Market Cap: $67B

Amerisourcebergen Corp
Non-Reccuring Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Amerisourcebergen Corp
Non-Reccuring Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Non-Reccuring Items CAGR 3Y CAGR 5Y CAGR 10Y
A
Amerisourcebergen Corp
LSE:0HF3
Non-Reccuring Items
-$1.3B
CAGR 3-Years
-60%
CAGR 5-Years
29%
CAGR 10-Years
-37%
Cardinal Health Inc
NYSE:CAH
Non-Reccuring Items
-$407m
CAGR 3-Years
37%
CAGR 5-Years
20%
CAGR 10-Years
-3%
Henry Schein Inc
NASDAQ:HSIC
Non-Reccuring Items
-$111m
CAGR 3-Years
5%
CAGR 5-Years
-28%
CAGR 10-Years
-12%
Patterson Companies Inc
NASDAQ:PDCO
Non-Reccuring Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mckesson Corp
NYSE:MCK
Non-Reccuring Items
$71m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cencora Inc
NYSE:COR
Non-Reccuring Items
-$1.3B
CAGR 3-Years
-60%
CAGR 5-Years
29%
CAGR 10-Years
-37%
No Stocks Found

Amerisourcebergen Corp
Glance View

AmerisourceBergen Corp., a titan in the realm of pharmaceutical services, orchestrates the flow of medications across a vast and intricate network. Rooted in Chesterbrook, Pennsylvania, the company has cemented its place as a critical link in the healthcare supply chain. Serving as a bridge between pharmaceutical manufacturers and a wide array of healthcare providers like hospitals, clinics, and pharmacies, AmerisourceBergen leverages its expansive distribution infrastructure to ensure that medications and health products reach their destinations efficiently and reliably. The company's operations are bolstered by its strategic partnerships and collaboration with a plethora of healthcare entities, enabling it to integrate seamlessly into the delivery systems that support patient care. At its core, AmerisourceBergen turns the complexity of healthcare logistics into a streamlined process, generating revenue primarily through the distribution of pharmaceuticals. It purchases medications from manufacturers, sells them at a markup to healthcare providers, and in doing so, balances a robust supply chain fueled by efficiency and scale. But the story doesn't end at distribution; the company has expanded its reach through value-added services such as consulting, data analytics, and patient support services that further solidify its role in the healthcare ecosystem. Whether navigating regulatory environments or advising on patient care strategies, AmerisourceBergen positions itself as not just a distributor, but a partner in health. Through this dual approach of distribution and strategic services, the company ensures it remains vital to both manufacturers and healthcare providers, creating a sustainable business model that capitalizes on both volume and innovation.

0HF3 Intrinsic Value
502.14 USD
Undervaluation 36%
Intrinsic Value
Price $323.26
A

See Also

What is Amerisourcebergen Corp's Non-Reccuring Items?
Non-Reccuring Items
-1.3B USD

Based on the financial report for Dec 31, 2025, Amerisourcebergen Corp's Non-Reccuring Items amounts to -1.3B USD.

What is Amerisourcebergen Corp's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 10Y
-37%

Over the last year, the Non-Reccuring Items growth was -25%. The average annual Non-Reccuring Items growth rates for Amerisourcebergen Corp have been -60% over the past three years , 29% over the past five years , and -37% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett